Search Orphan Drug Designations and Approvals
-
| Generic Name: | recombinant adeno-associated virus vector expressing ChronosFP |
|---|---|
| Date Designated: | 05/01/2025 |
| Orphan Designation: | treatment of retinitis pigmentosa |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Bionic Sight, Inc. 333 E 56th Street Suite 8E New York, New York 10065 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







